Kraig Biocraft Laboratories, Inc. Stock Other OTC

Kraig Biocraft Laboratories, Inc. develops fibers using recombinant deoxyribonucleic acid (DNA) technology for commercial applications in technical textiles. The Company uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Its primary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms. The Company’s products use the characteristics of spider silk, specifically dragline silk from Nephila clavipes and variants thereof. Its recombinant spider silk fiber blends the silk proteins found in spider silk with the native silkworm silk proteins. Its products include Monster Silk, Dragon Silk, Spydasilk and Spydra. Its applications include performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, and cosmetics, among others. The Company also focuses on developing various recombinant silks and other protein-based fibers and materials.